Thinking Out Loud (Blog)
December Newsletter: 2020 Hindsight! and Paying it Forward
2020 Hindsight and Paying it Forward It has been an upside down year during which time we've learned a lot about our ability to work from home and still carry out global collaborations. EpiVax embraces the positive changes that have occurred and celebrates the impact...
read more
November Newsletter: The What If Machine sees into the Future
The What If Machine, as applied to Immunogenicity Well Hello Again! Our PANDA program is back in the news. Having just completed validation studies on Salmon Calcitonin and Teriparatide, we're back in the business of predicting the future with the What If Machine!...
read more
September newsletter – Generic PANDA monium!
Generic PANDAmonium I have been hanging out with an old dog - eight year old Jack, during the COVID lockdown. If you are a dog during COVID-19, long walks, lots of snuggles on the couch during Zoom meetings, what's not to like? Hence the theme of my latest talk that...
read more
Time for T? Or, Are T-Cell-Driven Vaccines the Answer to COVID-19?
Time for T? Or Plan B for Operation Warp Speed? Six months ago, we asked if vaccine makers were rushing to “check the box” rather than spending time designing an effective vaccine (here is another link showing 'how to"). And have you noticed that all of the five top...
read more
Six months in, are we any closer to a vaccine?
Are we "Checking the Box" or Making Vaccines that work? We need a COVID-19 vaccine! From China to the US to Europe and even Africa, scientists are working tirelessly, if not at "warp speed", to develop and test more than one COVID-19 vaccine. May global scientific...
read more
Spy Vs Spy and … Making Better B-cell Derived Antibodies for COVID-19
Pepcid: From Poor Man's Cure to $20M COVID-19 Trial Remember Hydrocychloroquine? The drug that doesn't work for COVID-19? Well, here's some good news for you. A crazy rock climber/mountain rescue nut named Michael Callahan and a brilliant group of 3D modelers working...
read more